GLP1R in Parkinson's Disease
Trial
Phase 2
Unknown
Sept. 5, 2018
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Trial
Phase 2
Terminated
Sept. 5, 2018
Serotonin and Amyloidopathy
Trial
N/A
Completed
Sept. 4, 2018
Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy
Trial
Phase 4
Completed
Aug. 30, 2018
Outcomes Data of Adipose Stem Cells to Treat Parkinson's Disease
Trial
N/A
Unknown
Aug. 30, 2018
Dynamic ASPECTS of Internal PRE-ACTIVATION of Effects Sensors of Voluntary ACTION in PARKINSON's Disease
Trial
N/A
Completed
Aug. 30, 2018
GDNF in ideopathicParkinsons Disease
Trial
Phase 2
Completed
Aug. 28, 2018
Mutations Associated With Parkinson s Disease
Trial
N/A
Terminated
Aug. 28, 2018
N-Acetylcysteine for Neuroprotection in Parkinson's Disease
Trial
Phase 1
Completed
Aug. 27, 2018
Pain in Parkinson's Disease With Motor Fluctuations.
Trial
N/A
Unknown
Aug. 26, 2018
High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease
Trial
N/A
Completed
Aug. 26, 2018
Sleep, Awake & Move - Part II
Trial
N/A
Completed
Aug. 26, 2018
Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)
Trial
Phase 2
Completed
Aug. 22, 2018
Tryptophan Depletion in PD Patients Treated With STN DBS
Trial
N/A
Terminated
Aug. 21, 2018
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
Trial
N/A
Completed
Aug. 19, 2018
Autologous Mesenchymal Stem Cell Transplant for Parkinson's Disease
Trial
N/A
Terminated
Aug. 13, 2018
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Trial
Phase 3
Unknown
Aug. 13, 2018
Drug Interaction With Genes in Parkinson's Disease
Trial
N/A
Unknown
Aug. 12, 2018
Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528
Trial
Phase 3
Completed
Aug. 12, 2018
Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients
Trial
Phase 1
Withdrawn
Aug. 9, 2018